← FDA Drug Approvals (Drugs@FDA)

ENTRESTO

NDA · New Drug Application · Sponsor: NOVARTIS PHARMS CORP · Approved 2015-07-07

Drug application

FDA Application #

NDA207620

Application type

New Drug Application

Brand name

ENTRESTO

Generic name

SACUBITRIL AND VALSARTAN

Active ingredients

SACUBITRIL; VALSARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS PHARMS CORP

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2015-07-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown